🔥 GLP-1s are one of medicine's hottest topics—but what about dermatology? Join leading experts at #ODAC2027 to unpack the science, clinical considerations & aesthetic implications! 🔍 🔗 orlandoderm.org

🚨 Preventing seizure emergencies takes a team approach! Discover how multidisciplinary collaboration and emerging REST treatments may shape future epilepsy care. 💡 Explore the evidence! mdsc.pe/4zGNmKp

🧠Timing matters in seizure rescue. Explore REST, identify appropriate patients, and learn how to educate patients & caregivers on the critical window for intervention. 👥 🎟️ Register today! mdsc.pe/4B7UiCb

❓ Could B-cell depletion help reshape care in Sjögren’s disease? 🧬 Explore unmet needs, the mechanism of B-cell–depleting therapies, and key clinical data to strengthen your confidence in this evolving approach. Learn more: mdsc.pe/472IR0B

🔬 MDS treatment is evolving! Discover how cytogenetic and molecular characteristics inform treatment selection and how emerging clinical evidence can guide care. 💡 Expand your knowledge—join this educational activity! mdsc.pe/47pCQv9

🧬 New options are changing the R/R DLBCL treatment landscape! 🔬 At #ASH26, explore the latest bispecific antibody data, treatment sequencing & strategies for community practice. 🎯 Secure your spot: mdsc.pe/4yldhag

🧬 Discover the latest advances in platinum-resistant ovarian cancer from novel ADCs and emerging combination therapies to biomarker-driven treatment decisions. 👉 mdsc.pe/3TNOOvi #OvarianCancer #Oncology #PROC #ESMO

🧬 What's next in platinum-resistant ovarian cancer (PROC) care? Join @BanerjeeSusana to explore emerging ADCs, novel treatment combinations, and biomarker-guided strategies. #ESMO2026 🔍 Expand your knowledge—learn more! mdsc.pe/4dRs3xo

⚡ What’s next in focal epilepsy? Dive into the latest data on ASM limitations, patient symptom burden & emerging investigational therapies. 🧠 Discover tools to better evaluate patient-reported outcomes. Don’t miss out—save your spot! 🚀 mdsc.pe/4rxmycI

🧠 Are current antiseizure medications meeting patients' needs? Explore treatment limitations, ongoing symptom burden, and investigational therapies for focal epilepsy. 🔍 Expand your knowledge! mdsc.pe/3WjgCbO

🧩 Rett syndrome care requires an individualized approach! Discover how to recognize symptoms in male patients, address disease burden, and adapt treatment strategies across the lifespan. 💡 Enhance your expertise! mdsc.pe/4hWO4NP

🫘 Unmet needs remain in IgAN care! Explore how complement dysregulation contributes to glomerular injury and what emerging complement inhibitors could mean for future treatment. 🎯 Advance your clinical knowledge—learn more! mdsc.pe/4yTp7rX

💬 Beyond visible skin changes, vitiligo can significantly affect quality of life. Explore its psychosocial impact and learn how to translate clinical evidence into meaningful treatment conversations. 🔍 Expand your expertise! mdsc.pe/4yzwQLy

🧬 Choosing the right TKI in CML starts with the right data. Explore first-line selection, navigate resistance & translate mutational analysis into therapeutic decisions with coordinated team-based care. 🎯 Sharpen your CML strategy—register today! mdsc.pe/4zRXX6p #ASH26

⚖️ Can we improve stroke prevention while minimizing bleeding risk? Explore emerging anticoagulation approaches, including FXI/XIa inhibitors, and the latest evidence shaping the future of patient care. 🔬 #AAFPFMX

🎨 Take a closer look at the science of vitiligo! Explore how melanocyte disturbances contribute to disease pathology, uncover the role of JAK signaling, and examine the latest data on new and emerging JAK inhibitors. 🔎 mdsc.pe/4jqkZeD

🔬 Explore why ARPIs + ADT work in hormone-sensitive prostate cancer, 📊 review pivotal OS & progression data, 🎯 identify mHSPC vs nmCRPC candidates & 💪 start early intensification with confidence! mdsc.pe/4hLfKoS #ESMO

🫀 Repair or replace? Making the right decision for patients with symptomatic mitral regurgitation requires careful consideration. Explore emerging evidence + patient selection criteria. 🔎 Advance your expertise: mdsc.pe/3VJ22u0

🧬 Could factor XIa inhibition reshape secondary stroke prevention? Explore the science behind targeting factor XI/XIa, review the 🧪 latest trial data & identify patients who may benefit from this emerging approach. 🚀 Stay ahead of the evidence—register! mdsc.pe/4zL8kc1

📚 Learn from world-renowned dermatology experts at #PDElive27. 🧬 Dive into the latest clinical insights, practical approaches and evolving treatment strategies for pigmentary disorders.🔬 pigmentarydisorders.com